Back to top
more

Artivion (AORT)

(Real Time Quote from BATS)

$24.09 USD

24.09
87,951

+0.53 (2.25%)

Updated Jun 26, 2024 03:08 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 34% (164 out of 250)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for AORT

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for Artivion, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 59 39 55 62 34
Receivables 74 70 58 49 56
Notes Receivable 0 0 0 0 0
Inventories 82 74 77 73 53
Other Current Assets 66 64 58 51 44
Total Current Assets 281 247 248 235 187
Net Property & Equipment 38 39 38 33 32
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 1 1 2 1 5
Intangibles 420 426 452 487 344
Deposits & Other Assets 9 7 8 15 14
Total Assets 792 763 793 789 606
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 13 12 10 10 10
Current Portion Long-Term Debt 1 2 2 1 1
Current Portion Capital Leases 1 1 1 1 1
Accrued Expenses 33 28 25 21 23
Income Taxes Payable 4 3 4 3 3
Other Current Liabilities 2 1 1 19 2
Total Current Liabilities 58 50 45 60 45
Mortgages 0 0 0 0 0
Deferred Taxes/Income 29 30 35 40 30
Convertible Debt 0 0 0 0 0
Long-Term Debt 306 307 307 290 215
Non-Current Capital Leases 3 4 4 5 5
Other Non-Current Liabilities 71 47 56 50 7
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 511 478 492 461 320
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 356 337 323 316 272
Retained Earnings -48 -17 2 20 37
Other Equity -12 -22 -10 7 -9
Treasury Stock 15 15 15 15 15
Total Shareholder's Equity 282 284 301 329 286
Total Liabilities & Shareholder's Equity 792 763 793 789 606
Total Common Equity 282 284 301 329 286
Shares Outstanding 41.00 40.30 39.30 38.80 37.50
Book Value Per Share 6.87 7.06 7.65 8.47 7.62

Fiscal Year End for Artivion, Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents 51 59 53 49 31
Receivables 77 74 68 69 67
Notes Receivable 0 0 0 0 0
Inventories 82 82 79 78 76
Other Current Assets 67 66 67 67 67
Total Current Assets 277 281 267 264 241
Net Property & Equipment 38 38 37 38 39
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 1 1 4 4 2
Intangibles 413 420 415 423 426
Deposits & Other Assets 13 9 8 8 8
Total Assets 784 792 775 778 757
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable 0 0 0 0 0
Accounts Payable 10 13 11 10 9
Current Portion Long-Term Debt 0 1 2 2 2
Current Portion Capital Leases 0 1 0 0 0
Accrued Expenses 28 33 26 25 21
Income Taxes Payable 2 4 9 11 7
Other Current Liabilities 2 2 4 5 2
Total Current Liabilities 46 58 55 56 44
Mortgages 0 0 0 0 0
Deferred Taxes/Income 30 29 26 26 30
Convertible Debt 0 0 0 0 0
Long-Term Debt 313 306 306 306 306
Non-Current Capital Leases 3 3 3 3 4
Other Non-Current Liabilities 54 70 64 53
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 489 511 503 495 477
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 0 0
Capital Surplus 363 356 351 347 343
Retained Earnings -40 -48 -44 -34 -31
Other Equity -14 -12 -21 -16 -18
Treasury Stock 15 15 15 15 15
Total Shareholder's Equity 295 282 272 283 280
Total Liabilities & Shareholder's Equity 784 792 775 778 757
Total Common Equity 295 282 272 283 280
Shares Outstanding 41.20 41.00 41.00 41.00 40.80
Book Value Per Share 7.16 6.87 6.63 6.89 6.86